Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
- PMID: 29856689
- DOI: 10.1200/JCO.2018.78.0031
Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
Comment in
-
Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al.J Clin Oncol. 2018 Aug 1;36(22):2351-2352. doi: 10.1200/JCO.2018.78.2144. Epub 2018 Jun 1. J Clin Oncol. 2018. PMID: 29856691 No abstract available.
-
Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al.J Clin Oncol. 2018 Aug 1;36(22):2352-2353. doi: 10.1200/JCO.2018.78.2151. Epub 2018 Jun 1. J Clin Oncol. 2018. PMID: 29856697 No abstract available.
Comment on
-
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.J Clin Oncol. 2018 Feb 10;36(5):446-453. doi: 10.1200/JCO.2017.75.4853. Epub 2017 Dec 14. J Clin Oncol. 2018. PMID: 29240541 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
